Dr Lal Pathlabs

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE600L01024
  • NSEID: LALPATHLAB
  • BSEID: 539524
INR
1,407.40
-12.75 (-0.9%)
BSENSE

Feb 03

BSE+NSE Vol: 3.11 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Thyrocare Tech.
Indegene
Dr Lal Pathlabs
Poly Medicure
Vijaya Diagnost.
Vimta Labs
Syngene Intl.
Suven Life Scie.
Metropolis Healt
Nephrocare Healt
Krsnaa Diagnost.
Why is Dr Lal Pathlabs Ltd ?
1
High Management Efficiency with a high ROE of 20.98%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 14.39% and Operating profit at 19.92% over the last 5 years
4
The company has declared Positive results for the last 3 consecutive quarters
  • PAT(9M) At Rs 437.60 cr has Grown at 36.71%
  • NET SALES(Q) Highest at Rs 730.60 cr
  • PBDIT(Q) Highest at Rs 224.10 cr.
5
With ROE of 22.4, it has a Very Expensive valuation with a 10.5 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 1.40%, its profits have risen by 33.1% ; the PEG ratio of the company is 1.4
6
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -0.58% over the previous quarter and currently hold 53.21% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Dr Lal Pathlabs for you?

Medium Risk, Medium Return

Absolute
Risk Adjusted
Volatility
Dr Lal Pathlabs
-0.67%
0.05
27.42%
Sensex
8.49%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
12.89%
EBIT Growth (5y)
15.70%
EBIT to Interest (avg)
18.64
Debt to EBITDA (avg)
0.42
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
1.10
Tax Ratio
19.52%
Dividend Payout Ratio
42.00%
Pledged Shares
0
Institutional Holding
39.50%
ROCE (avg)
60.59%
ROE (avg)
20.98%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
43
Industry P/E
56
Price to Book Value
9.88
EV to EBIT
36.71
EV to EBITDA
29.34
EV to Capital Employed
18.06
EV to Sales
8.43
PEG Ratio
1.35
Dividend Yield
0.89%
ROCE (Latest)
47.69%
ROE (Latest)
22.38%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-1What is not working for the Company
EPS(Q)

Lowest at Rs 5.40

Loading Valuation Snapshot...
Here's what is not working for Dr Lal Pathlabs
Earnings per Share (EPS) - Quarterly
Lowest at Rs 5.40
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)